Since the mid 1990’s, Schuster, together with collaborators at various academic and commercial international institutions, has demonstrated the transformative impact of genomics on the Life Sciences, in particular through next-generation sequencing technology (1,2,3).
In 2016, Schuster and Mahesh Pratapneni, with support from the Nanyang Technological University, EmergeVentures, Medgenome, and Macrogene, founded the GenomeAsia100K initiative, which sequences human genomes from Asian human populations.